Tvardi Therapeutics, Inc. (TVRD) — Tangible Net Worth Ratio
Tvardi Therapeutics, Inc. (TVRD) has a Tangible Net Worth Ratio of 98.8% as of September 2025. This metric is calculated by deducting intangible assets ($338.00K) from net assets ($27.87 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Tvardi Therapeutics, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tvardi Therapeutics, Inc. Tangible Net Worth Ratio (2020–2021)
This chart shows how Tvardi Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 2 annual periods from 2020 to 2021. As of September 2025, the ratio stands at 98.8%, reflecting net assets of $27.87 Million with intangible assets of $338.00K USD. See TVRD defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Tvardi Therapeutics, Inc. (2020–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for Tvardi Therapeutics, Inc. from 2020 to 2021, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Tvardi Therapeutics, Inc..
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $227.52 Million | $0.00 | $247.06 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $249.00 Million | $0.00 | $271.16 Million | — |